Literature DB >> 29955915

Patent foramen ovale closure for patients excluded from the randomized cryptogenic stroke trials.

Muhammad O Zaman1,2, Nimesh K Patel3, Mohammad K Mojadidi4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29955915     DOI： 10.1007/s00392-018-1305-4

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  7 in total

Review 1.  Patent foramen ovale: Unanswered questions.

Authors:  Mohammad Khalid Mojadidi; Panagiota Christia; Jason Salamon; Jared Liebelt; Tarique Zaman; Rubine Gevorgyan; Nariman Nezami; Sanaullah Mojaddedi; Islam Y Elgendy; Jonathan M Tobis; Robert Faillace
Journal:  Eur J Intern Med       Date:  2015-10-17       Impact factor: 4.487

Review 2.  Cryptogenic Stroke and Patent Foramen Ovale.

Authors:  Mohammad K Mojadidi; Muhammad O Zaman; Islam Y Elgendy; Ahmed N Mahmoud; Nimesh K Patel; Nayan Agarwal; Jonathan M Tobis; Bernhard Meier
Journal:  J Am Coll Cardiol       Date:  2018-03-06       Impact factor: 24.094

3.  Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.

Authors:  Pil Hyung Lee; Jae-Kwan Song; Jong S Kim; Ran Heo; Sahmin Lee; Dae-Hee Kim; Jong-Min Song; Duk-Hyun Kang; Sun U Kwon; Dong-Wha Kang; Dongwhane Lee; Hyuk Sung Kwon; Sung-Cheol Yun; Byung Joo Sun; Jae-Hyeong Park; Jae-Hwan Lee; Hye Seon Jeong; Hee-Jung Song; Jei Kim; Seung-Jung Park
Journal:  J Am Coll Cardiol       Date:  2018-03-12       Impact factor: 24.094

4.  Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.

Authors:  Jean-Louis Mas; Geneviève Derumeaux; Benoît Guillon; Evelyne Massardier; Hassan Hosseini; Laura Mechtouff; Caroline Arquizan; Yannick Béjot; Fabrice Vuillier; Olivier Detante; Céline Guidoux; Sandrine Canaple; Claudia Vaduva; Nelly Dequatre-Ponchelle; Igor Sibon; Pierre Garnier; Anna Ferrier; Serge Timsit; Emmanuelle Robinet-Borgomano; Denis Sablot; Jean-Christophe Lacour; Mathieu Zuber; Pascal Favrole; Jean-François Pinel; Marion Apoil; Peggy Reiner; Catherine Lefebvre; Patrice Guérin; Christophe Piot; Roland Rossi; Jean-Luc Dubois-Randé; Jean-Christophe Eicher; Nicolas Meneveau; Jean-René Lusson; Bernard Bertrand; Jean-Marc Schleich; François Godart; Jean-Benoit Thambo; Laurent Leborgne; Patrik Michel; Luc Pierard; Guillaume Turc; Martine Barthelet; Anaïs Charles-Nelson; Christian Weimar; Thierry Moulin; Jean-Michel Juliard; Gilles Chatellier
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

5.  Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.

Authors:  Jeffrey L Saver; John D Carroll; David E Thaler; Richard W Smalling; Lee A MacDonald; David S Marks; David L Tirschwell
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

Review 6.  Patent foramen ovale closure versus medical therapy for prevention of recurrent cryptogenic embolism: updated meta-analysis of randomized clinical trials.

Authors:  Brunilda Alushi; Alexander Lauten; Salvatore Cassese; Roisin Colleran; Stefanie Schüpke; Himanshu Rai; Heribert Schunkert; Bernhard Meier; Ulf Landmesser; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2018-04-11       Impact factor: 5.460

7.  The risk of paradoxical embolism (RoPE) study: initial description of the completed database.

Authors:  David E Thaler; Emanuele Di Angelantonio; Marco R Di Tullio; Jennifer S Donovan; John Griffith; Shunichi Homma; Cheryl Jaigobin; Jean-Louis Mas; Heinrich P Mattle; Patrik Michel; Marie-Luise Mono; Krassen Nedeltchev; Federica Papetti; Robin Ruthazer; Joaquín Serena; Christian Weimar; Mitchell S V Elkind; David M Kent
Journal:  Int J Stroke       Date:  2012-08-09       Impact factor: 5.266
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.